HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

​ Conditions: Pancreatic Cancer

Interventions: Drug: HRS-4642+AG +Adebrelimab

Sponsors: Ruijin Hospital; Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting Conditions: Pancreatic Cancer
Interventions: Drug: HRS-4642+AG +Adebrelimab
Sponsors: Ruijin Hospital; Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting